For Research Purposes Only — Not for Human Consumption
Tirzepatide Oral Capsules 5mg x30
Minimum 2 bottles required ($198.00 total)
Compound Overview & Research Information
Tirzepatide oral capsules, 5mg per capsule, 30-count bottle. Oral dual GIP/GLP-1 co-agonist formulation for metabolic research investigating incretin receptor pharmacology via the enteric route. Used in preclinical models studying oral peptide bioavailability and combinatorial incretin effects on energy homeostasis. For laboratory research only.
Laboratory Specifications
Accepted Payment Methods
This product is intended strictly for laboratory and in-vitro research. It has not been evaluated by the FDA and is not approved for human consumption, therapeutic use, or veterinary application. Always consult primary peer-reviewed literature and a qualified professional before drawing conclusions about any compound.
Everything You Need To Know About Tirzepatide Oral Capsules 5mg x30
Is Tirzepatide Oral Capsules 5mg x30 intended for human use?
How long does it take for an order of Tirzepatide Oral Capsules 5mg x30 to ship?
Capsules
